Pertuzumab plus trastuzumab and chemotherapy for HER2-positive metastatic gastric or gastro-oesophageal junction cancer (JACOB): final analysis of a double-blind, randomised, placebo-controlled phase 3 study

著者: Josep Tabernero, Paulo M. Hoff, Lin Shen, Atsushi Ohtsu, Manish A. Shah, Karen Cheng, Chunyan Song, Haiyan Wu, Jennifer Eng‐Wong, Katherine Kim, Yoon‐Koo Kang - The Lancet 2018 被引用: 478